Form 4: Amphastar Pharmaceuticals CFO William J. Peters Reports Acquisition of Stock Options and Restricted Stock Units

William J. Peters, CFO, EVP & Treasurer of Amphastar Pharmaceuticals, reports the acquisition of stock options and restricted stock units.

Summary

• On March 4, 2024, William J. Peters, CFO, EVP & Treasurer of Amphastar Pharmaceuticals, acquired 40,955 employee stock options with an exercise price of $46.68, vesting in four equal annual installments beginning March 4, 2025, and expiring on March 4, 2034.
• Peters also acquired 19,440 restricted stock units (RSUs) that vest in four equal annual installments beginning on March 4, 2025.
• Following these transactions, Peters directly owns 40,955 derivative securities and 120,800 shares of common stock.

Sentiment

Score: 6

Explanation: Neutral sentiment. The filing simply reports transactions by an insider, which could be interpreted as a sign of confidence, but without further context, it's difficult to assign a strong positive or negative sentiment.

Positives

• The acquisition of stock options and RSUs by a key executive could be seen as a positive sign, indicating confidence in the company's future performance.

Industry Context

Form 4 filings are a routine part of the regulatory landscape for publicly traded companies, providing transparency into the transactions of company insiders.

Stakeholder Impact

• The transactions could have a minor positive impact on shareholder sentiment if viewed as a sign of confidence by the CFO.

Key Dates